Comparative Pharmacology
Head-to-head clinical analysis: AMCILL versus AMPICILLIN TRIHYDRATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMCILL versus AMPICILLIN TRIHYDRATE.
AMCILL vs AMPICILLIN TRIHYDRATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and autolysin activity.
250-500 mg orally every 8 hours or 500 mg every 12 hours; for severe infections, up to 1 g every 6 hours intravenously.
250-500 mg PO q6h or 1-2 g IV/IM q4-6h; up to 12 g/day IV for severe infections.
None Documented
None Documented
1-1.5 hours in normal renal function; prolonged to 7-10 hours in anuria.
Terminal elimination half-life 1-1.8 hours; prolonged in renal impairment (up to 10-20 hours in anuria)
Renal: 60-80% unchanged; biliary: less than 10%; fecal: small amount.
Renal: 75-90% unchanged; biliary: small amount; fecal: negligible
Category C
Category A/B
Penicillin Antibiotic
Penicillin Antibiotic